Novel EP4 Receptor Agonist-Bisphosphonate Conjugate Drug (C1) Promotes Bone Formation and Improves Vertebral Mechanical Properties in the Ovariectomized Rat Model of Postmenopausal Bone Loss

Effect of Low-Magnitude Whole-Body Vibration Combined with Alendronate in Ovariectomized Rats: A Random Controlled Osteoporosis Prevention Study

(2014) Guo-Xian Chen et al.   PLoS One

Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis

(2012) Steve Arns et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee

(2012) David W Dempster et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The role of the EP receptors for prostaglandin E2 in skin and skin cancer

(2011) J. E. Rundhaug et al.   CANCER AND METASTASIS REVIEWS

International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress

(2011) D. F. Woodward et al.   PHARMACOLOGICAL REVIEWS

Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: Induction of a transition from nonadherent to adherent osteoblast precursors

(2010) Andrew Scutt et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats

(2010) J. Gregory Seedor et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats

(2010) D.B. Lauritzen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Continuous PGE2 leads to net bone loss while intermittent PGE2 leads to net bone gain in lumbar vertebral bodies of adult female rats

(2008) X.Y. Tian et al.   BONE

Normal Bone Anatomy and Physiology

(2008) B. Clarke   Clinical Journal of the American Society of Nephrology

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy

(2008) R. G. G. Russell et al.   OSTEOPOROSIS INTERNATIONAL

Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib

(2006) Tasuku Mashiba et al.   JOURNAL OF BONE AND MINERAL RESEARCH